IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

To investigate the impact of pre-transplant CMV serostatus of donor or recipient on outcome of patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-SCT) for Multiple Myeloma (MM). To our knowledge no data are available in the literature about this issue. We retrospectively f...

Full description

Saved in:

Bibliographic Details
Main Author:	Jean Elcheikh
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-04-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	CMV serostatus, allogeneic-SCT, Reduced-intensity conditioning, Multiple Myeloma.
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/438
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation
by: Kentaro Ushijima, et al.
Published: (2025-01-01)

UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant
by: Richard LeBlanc, et al.
Published: (2024-11-01)

Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial
by: Hans Salwender, et al.
Published: (2024-12-01)

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study)
by: Annemarie Glöckner, et al.
Published: (2025-01-01)

Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
by: Lauren Ogawa, et al.
Published: (2024-12-01)

CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
by: omar ziad alrawi, et al.
Published: (2015-08-01)

"ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"
by: Benedetto Bruno, et al.
Published: (2010-06-01)

JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.
by: jean elcheikh
Published: (2012-06-01)

JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.
by: jean elcheikh
Published: (2012-01-01)

DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN HIGH RISK NEONATES
by: Ehab abdelmoniem Albanna, et al.
Published: (2013-07-01)

Congenital cytomegalovirus - current state of knowledge on the treatment and prevention of fetuses and newborns
by: Katarzyna Miedzińska, et al.
Published: (2025-01-01)

Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience
by: Zhivka Stoykova, et al.
Published: (2024-12-01)

Cytomegalovirus (CMV) immunoglobulin antibodies: Prevalence and associated characteristics among blood donors from a university teaching hospital in Nigeria
by: Ramoni Ayodele Bolarinwa, et al.
Published: (2014-08-01)

DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.
by: Federica Sorà, et al.
Published: (2020-08-01)

Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection
by: Aura Temereanca, et al.
Published: (2025-01-01)

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01)

Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
by: Alex Shimanovsky, et al.
Published: (2016-01-01)

Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Qiaozhu Zeng, et al.
Published: (2025-01-01)

Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV)
by: Jennifer L. Rossen, et al.
Published: (2025-01-01)

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
by: Guangqiang Meng, et al.
Published: (2025-01-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Patrizia Chiusolo, et al.
Published: (2010-05-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01)

Correlation of Interleukin-10 and Interleukin-8 with Cytomegalovirus and Epstein–Barr Virus Infection in Hemodialysis Patients
by: Eman Ammar Ihsan, et al.
Published: (2024-10-01)

Beyond Awareness: Hope for a CMV Vaccine! An Introduction to the Conference, “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
by: Megan H. Pesch, et al.
Published: (2024-10-01)

Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
by: Mark R. Schleiss, et al.
Published: (2024-10-01)

Spontaneous pneumothorax in an allogeneic cell transplant recipient with invasive pulmonary aspergillosis and antecedent RSV pneumonitis
by: Liang Piu Koh, et al.
Published: (2011-03-01)

Spontaneous pneumothorax in an allogeneic cell transplant recipient with invasive pulmonary aspergillosis and antecedent RSV pneumonitis
by: John K Tam, et al.
Published: (2011-01-01)

Study of the Prevalence of Cytomegalovirus in Children with Malignancy in Southwestern Iran from 2016-2023
by: Arash Alghasi, et al.
Published: (2025-01-01)

Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
by: Danilo De Novellis, et al.
Published: (2024-07-01)

Progress and Challenges in the Management of Congenital Cytomegalovirus Infection
by: Weronika Szulc, et al.
Published: (2024-11-01)

QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Alhossain A. Khalafallah, et al.
Published: (2011-11-01)

QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Iain Robertson, et al.
Published: (2011-01-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
by: Gabriele Magliano, et al.
Published: (2020-10-01)

Experience of BK Virus in Allogenic and Autologous Bone Marrow Transplantation:
by: Ilhami BERBER, et al.
Published: (2014-08-01)

SOCIAL COGNITIVE DETERMINANTS OF PHYSICAL ACTIVITY IN A PREDOMINANTLY HISPANIC COLLEGE POPULATION
by: Dejan Magoc, et al.
Published: (2010-06-01)

Assessing the Validity and Effectiveness of Student Worksheets and Creativity Tests in Enhancing the Creativity of Open University Students
by: Dwikoranto Dwikoranto, et al.
Published: (2024-04-01)

SUBSTANTIATION OF APPLICATION OF ALLOGENIC FIBROBLASTS IN TREATMENT OF EXTENSIVE BURNS
by: E. Ya. Fistal’, et al.
Published: (2017-02-01)

Screening among Pregnant Women for Cytomegalovirus (CMV) Infection — Recommendations in Poland and Selected Countries Worldwide (a Preliminary Study to Investigate the Incidence of Neurological Complications in CMV — Infected Children)
by: Adrianna Frydrysiak-Brzozowska, et al.
Published: (2022-06-01)

Pretransplant hypoalbuminemia may be associated with poor survival in patients that underwent autologous hematopoietic stem cell transplantation (autoHSCT)
by: Serdar Sivgin, et al.
Published: (2014-08-01)